Hypertension. Other secondary pulmonary hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age = 60 years, and provision of informed consent. Obesity (BMI = 30 kg/m²) stage 1 or 2 hypertension on stable pharmacological treatment Medical clearance for moderate-intensity exercise Absence of acute cardio-pulmonary diseases No regular participation in structured exercise programs or a low-sodium diet in the past 6 months
Exclusion criteria
Exclusion criteria: Serious or uncontrolled comorbidities (e.g., cardiovascular, pulmonary, renal, or diabetes). Use of medications affecting blood pressure or body weight (other than stable antihypertensive therapy) Having severe orthopedic limitations Active smoking within the past year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic and Diastolic Blood Pressure. Timepoint: Study baseline, Week 6, and post-intervention at Week 12. Method of measurement: Measured using a calibrated digital sphygmomanometer after 5 minutes of seated rest.;Forced Expiratory Volume in 1 second (FEV1). Timepoint: Study baseline and post-intervention at Week 12. Method of measurement: Measured using a spirometer according to standard ATS/ERS guidelines.;Forced Vital Capacity (FVC). Timepoint: Study baseline and post-intervention at Week 12. Method of measurement: Measured using a spirometer according to standard ATS/ERS guidelines.;FEV1/FVC Ratio. Timepoint: Study baseline and post-intervention at Week 12. Method of measurement: Measured using a spirometer according to standard ATS/ERS guidelines. | — |
Countries
Iran (Islamic Republic of)
Contacts
Razi University